Video Shorts

#9: Complete Response Letters

#10: Drug Pipeline Report

The Power of Automation

AI Agents in Pharmacy

The Rise of Oral GLP-1's

The Impact of FDA's Approval of Papzimeos

The Hidden Cost of Unmanaged Kidney Disease Complications

How the DSCSA is Accelerating Digital Transformation

The GLP-1 Shift to Mass Market

FDA's Priority Voucher Review Program's Impact on Timelines

Why Platform Technologies are Essential for Biotech Investors

Why Upfront Molecular Testing is the Future of Systemic Therapy

Strategizing for Growth in 2025

Balancing Innovation and Capital

AI's Recent Advancements in the Pharmaceutical Industry

Fixing Drug Supply Chains

Approaching Inclusivity and Representation in the Development and Communication of Biomarker-Driven Diagnostics

Understanding Volatility Over a 16-Quarter Presidency in Biopharma

Transforming Care from Discovery to Delivery

MJH Buys BPD: Expanding Reach to Clinicians, Patients

The Problems DTC Can Address

What Makes TrumpRx Unique

Looming DSCSA Enforcement

Transitioning from COO to CEO

Obesity Medication's Unique Marketing Environment

AI at FDA

Preparing for Tariffs

Federated Data Networks

The Breakthrough of Multiomics

Regulatory Uncertainty